Female rats are less susceptible during puberty to the lethal effects of percutaneous exposure to VX  by Wright, Linnzi K.M. et al.
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a  b  s  t  r  a  c  t
Nerve  agents  with  low  volatility  such  as VX  are  primarily  absorbed  through  the  skin  when  released  during
combat  or  a  terrorist  attack.  The  barrier  function  of  the  stratum  corneum  may  be  compromised  during
certain  stages  of  development,  allowing  VX  to more  easily  penetrate  through  the  skin.  However,  age-
related  differences  in  the  lethal  potency  of  VX  have  yet  to be  evaluated  using  the  percutaneous  (pc) route
of exposure.  Thus,  we estimated  the  24  and  48 h  median  lethal  dose  for pc exposure  to  VX  in male and
female  rats  during  puberty  and  early  adulthood.  Pubescent,  female  rats  were  less susceptible  than  both
their male  and  adult  counterparts  to the  lethal  effects  associated  with  pc exposure  to  VX possibly  because
of  hormonal  changes  during  that  stage  of development.  This  study  emphasizes  the  need  to  control  for
both  age  and sex  when  evaluating  the  toxicological  effects  associated  with  nerve  agent  exposure  in theeywords:
edian lethal dose
erve agent
ercutaneous
uberty
at
rat model.
Published by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).X
. Introduction
Aum Shinrikyo, the religious cult responsible for the release
f the nerve agent sarin in the Tokyo subway system, used VX
n as many as ﬁve assassination attempts in the mid-1990s [29].
orimoto et al. [18] describe the symptoms (miosis, excessive
erspiration, diarrhea, hypothermia, muscle fasciculations and
ulmonary edema) experienced by one of the victims before
e died sixteen days after being injected in the neck with VX.
oth nerve agents cause lethality by irreversibly binding to
cetylcholinesterase (AChE) and inhibiting the hydrolysis of the
eurotransmitter acetylcholine; however, VX is three orders of
agnitude less volatile than sarin and primarily enters the circula-
Abbreviations: (AChE), acetylcholinesterase; (ANOVA), analysis of variance;
BARDA), Biomedical Advanced Research and Development Authority; (CI), conﬁ-
ence interval; (LD50), median lethal dose; (pc), percutaneous or percutaneously;
PND), postnatal day; (SC), subcutaneous or subcutaneously; (TEWL), transepider-
al  water loss; (USAMRICD), US Army Medical Research Institute of Chemical
efense.
∗ Corresponding author. Fax: +1 410 436 8377.
E-mail addresses: lucille.a.lange.civ@mail.mil, lucylange@gmail.com
L.A. Lumley).
ttp://dx.doi.org/10.1016/j.toxrep.2015.12.003
214-7500/Published by Elsevier Ireland Ltd. This is an open access article under the CC Btory system through the skin rather than the lungs when released
in a battleﬁeld or terrorist situation (reviewed in Ref. [19])
The outermost layer of the skin, or stratum corneum, is the
major barrier against percutaneous (pc) exposure to VX, and vari-
ables related to its function (hydration, lipid content, pH, thickness,
sebum production and transepidermal water loss [TEWL]) change
with age [3,14,15]. As reviewed in Ref. [28], the barrier function of
the stratum corneum is not fully competent at time of birth. Infants
(deﬁned as individuals between birth and 3 years of age) have thin-
ner, less acidic and more hydrated strata cornea than young adults
(deﬁned as individuals between 20 and 40 years of age) with sim-
ilar or higher TEWL values depending on the anatomic location,
suggesting that VX may  be able to more easily penetrate through
the skin during the ﬁrst years of life. In fact, Ngawhirunpat et al.
[21] showed that the permeability coefﬁcients for lipophilic com-
pounds (log Kow = 2.09 for VX; [20]) through intact skin are higher
for postnatal day (PND) 5 rats than for any other age group (up to
PND 180).
The barrier function of the stratum corneum may  also be com-
promised during puberty. Compared to adults, pubescent children
(deﬁned as individuals between 10 and 14 years of age) have drier
skin with similar or higher TEWL values depending on the anatomic
location [1]. In addition, the surge of hormones during puberty
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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riggers a rapid increase in sebum production and causes females,
ut not males, to accumulate a thick layer of subcutaneous (sc) fat
reviewed in Ref. [13]). Thus, pubescent children are likely to be
ore vulnerable than adults to the toxic effects associated with pc
xposure to VX.
The goal of this study was to evaluate the lethal potency of VX
uring puberty and early adulthood in the rat model. Using a stage-
ise, adaptive dose design, we estimated the 24 and 48 h LD50 for
c exposure to VX in male and female rats for two  different age
roups (PND 42 and 70). PND 70 rats were chosen to model the typ-
cal combat soldier between 18- and 25-years old. Unfortunately,
e were unable to estimate the LD50 for younger age groups of rats
s the digital syringe was not sensitive enough to apply the picoliter
uantities of VX that would be needed due to the low body weight
f rats younger than PND 42. Nevertheless, we found pubescent,
emale rats to be less susceptible (higher LD50 values) than their
dult counterparts to the lethal effects associated with pc expo-
ure to VX. However, age-related differences in the lethal potency
f VX were not observed with the male rats.
. Methods
.1. Animals
Male and female Sprague-Dawley rats (CD IGS) were purchased
rom Charles River Laboratories International, Inc. (Kingston, NY)
nd divided into two groups based on their age (PND 42 and 70).
he pre-exposure weights of each age group and sex are listed
n Table 1. Rats were individually housed in temperature- and
umidity-controlled rooms (21 ± 2 ◦C and 60 ± 20%, respectively)
nder a 12:12 h light:dark cycle (lights on at 06:00). Food and water
ere available ad libitum. The experimental protocol was  approved
y the Animal Care and Use Committee at the US Army Medical
esearch Institute of Chemical Defense (USAMRICD), and all pro-
edures were conducted in accordance with the principles stated
n the Guide for the Care and Use of Laboratory Animals, the most
urrent Public Health Safety Policy on Humane Care and Use of Lab-
ratory Animals and the Animal Welfare Act of 1966 (P.L. 89-544),
s amended.
.2. Animal preparation
Approximately 24 h prior to the exposures, the fur on the right
ank of each rat was clipped with a Dander-free Clipper System
Hazard Technology; Pasadena, MD)  equipped with an Oster A5
lipper and a #40 CryogenX blade (Boca Raton, FL). Care was taken
o limit razor burn, and VX was not applied to an area with visible
brasions. On the morning of the exposures, the rats were moved
o a procedure room with a bank of chemical fume hoods. A circle
2.5 cm in diameter) was drawn on the clipped ﬂank of each rat with
 black permanent marker (Sharpie; Downers Grove, IL). Each rat
as then ﬁtted with an Elizabethan collar (Lomir Biomedical, Inc.;
alone, NY), placed in a polycarbonate cage (16.5 cm wide × 19 cm
ong × 21.5 cm high) lined with an iso-PAD (Harland Laboratories,
nc.; Indianapolis, IN) and moved into one of the hoods where it
emained for the rest of the study.
.3. Agent application
VX (ethyl-S-dimethylaminoethyl methylphosphonothiolate)
as obtained from the US Army Edgewood Chemical Biological
enter (Aberdeen Proving Ground, MD). Using methods similar to
hose described by Clarkson et al. [4], VX was applied in its neat
undiluted) form using a digital 0.5 l syringe with 2.5 nl incre-
ents (Hamilton Laboratory Products; Reno, NV) to the center
f the circle drawn on each un-anesthetized rat. The volume ofReports 3 (2016) 895–899
VX applied to each rat ranged from 2.5 to 115 nl, and the spe-
ciﬁc gravity of VX (1.01 g/ml) along with each rat’s body weight
was used to calculate the dose that was administered. Exposures
were conducted between 09:00 and 11:00, and toxic signs (abnor-
mal  mouth movements, convulsions, forelimb clonus, lacrimation,
muscle fasciculations, salivation and tremors) were continuously
monitored throughout the business day. Survivors were euthanized
at 48 h post-exposure with Fatal-Plus (Vortech Pharmaceuticals,
Ltd.; Dearborn, MI), and tissue samples were collected and archived
in a −80 ◦C freezer for future analyses.
2.4. LD50 estimations
The 24 and 48 h lethality for pc exposure to VX was  estimated
by establishing dose-response curves, and each curve was gener-
ated using a stagewise, adaptive dose design [8–10]. In the ﬁrst
stage, three doses (n = 2–3 rats/dose) were selected to span the pre-
dicted range of lethality from 0 to 100%. The lethality results from
the ﬁrst stage were used to select doses (n = 1–3 rats/dose) for the
second stage. In the subsequent stages, doses were selected to fur-
ther focus on a 50% lethality response and/or to better estimate
the dose–response curve. After each stage, probit dose–response
models using maximum likelihood methods were ﬁtted to the com-
bined data for all stages [9,11]. The stage process continued until
the half width of the 95% conﬁdence interval (CI) deﬁned as (Upper
Bound–Lower Bound)/(2 × LD50) for the 48 h LD50 was  less than 0.4
or a maximum of 30 rats was  used for each age group and sex.
2.5. Statistical analyses
The 24 and 48 h LD50 values for pc exposure to VX were esti-
mated by probit analysis using SAS NLIN (SAS Institute, Cary, NC)
and the specialized programs of Feder et al. [8–10]. The delta
method was  used to compute a 95% CI for each LD50 value. Com-
parisons between male and female LD50 values for each age group,
as well as comparisons between age groups within each sex, were
made by calculating a comparative ratio of the two  LD50 values
along with a 95% CI for that ratio. This approach is a variation of
the two-sided Z-test (  ˛ = 0.05). If the 95% CI for the comparative
ratio did not encompass the value of 1.0, then the LD50 values of
the age groups or sexes being compared were determined to be sig-
niﬁcantly (p < 0.05) different. SigmaPlot 12.3 (Systat Software, San
Jose, CA) was used to plot the dose–response curves.
3. Results
3.1. LD50 estimates
Table 2 shows the 24 and 48 h LD50 values for each group of rats
pc exposed to VX. For PND 42 rats, males had signiﬁcantly lower
LD50 values than females. No sex differences were observed for
PND 70 rats. For males, no age-related differences were observed.
For females, however, the 48 h LD50 value for PND 70 rats was  lower
than the value for PND 42 rats. No other signiﬁcant differences were
observed for females.
3.2. Dose–response curves
Fig. 1 shows the dose–response curves for each group of rats pc
exposed to VX. No differences were observed for males. For females,
however, the dose–response curves for PND 42 rats were shifted to
the right compared to PND 70 rats, implying that VX was  less potent
when administered to rats during puberty.
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Table  1
Body weight (mean ± standard deviation) for male and female rats during puberty and early adulthood. The body surface area for each rat was calculated using the equation
of  Spiers and Candas [27], which takes into account the different stages of development. This value was  then divided by the rat’s body weight to give a body surface area to
body  weight ratio. A two-way analysis of variance (ANOVA) with age group and sex as factors was conducted to determine differences in these ratios. There was a signiﬁcant
interaction between the two factors (F(1,113) = 14.6, p < 0.001); thus, a t-test was conducted for each sex to determine differences between age groups.
Male Female
Group Weight (g) Surface area (cm2) Ratio (cm2/g) N Weight (g) Surface area (cm2) Ratio (cm2/g) N
PND 42 231 ± 14 380 ± 17 1.63 ± 0.03* 26 170 ± 7 302 ± 10 1.77 ± 0.02* 24
PND  70 353 ± 13 516 ± 14 1.46 ± 0.01 23 232 ± 12 379 ± 15 1.63 ± 0.02 24
* Signiﬁcant (p < 0.05) differences.
Table 2
24 and 48 h LD50 values and 95% CI for male and female rats pc exposed to VX during puberty or early adulthood. Comparisons were made between sexes for each time and
age  group, and signiﬁcant (p < 0.05) differences are highlighted in bold.
Group 24 h 48 h
Male Female Male Female
LD50 (g/kg)95% CISlope ± SEN PND 42 41.2 32.9–51.7 8.8 ± 3.9 26 69.961.1–80.014.5 ± 3.624 41.2 32.9–51.7 8.8 ± 3.9 26 69.9*61.1–80.014.5 ± 3.624
LD50 (g/kg)95% CISlope ± SEN PND 70 43.138.5–48.219.2 ± 5.823 50.8 36.3–71.2 4.5 ± 3.8 24 38.433.5–44.016.0 ± 2.823 42.8 29.3–62.6 4.6 ± 2.8 24
* Signiﬁcant (p < 0.05) differences between age groups for each time and sex.
F  pube
4
3
aig. 1. Dose–response curves for male and female rats pc exposed to VX during
8  h—females..3. Toxic signs
The ﬁrst toxic sign observed for nearly 80% of the rats was
bnormal mouth movements (chewing, oral tonus and/or tonguerty or early adulthood. (A) 24 h—males; (B) 24 h—females; (C) 48 h—males; (D)fasciculations). Approximately 22% of the rats that died from pc
exposure to VX had generalized motor convulsions as deﬁned
by Racine [22], and no statistical differences (Fisher’s exact test;
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 > 0.05) were observed between groups in terms of the number
f rats that experienced convulsions. For those that died dur-
ng the ﬁrst business day, the latency to death was  85 ± 54 min
range: 12–221 min) for PND 42 rats and 136 ± 103 min  (range:
5–372 min) for PND 70 rats. There were no deaths among the
ubescent age group between 24 and 48 h post-exposure.
. Discussion
Skin is the largest and outermost organ of the body compris-
ng over 15% of an animal’s body mass [7]. Its major functions are
o protect against water loss and prevent exogenous substances
ike VX from entering the body. These functions, however, may  be
ompromised during an animal’s development including puberty.
hus, we estimated LD50 values for pc exposure to VX in male and
emale rats at two different times in development (PND 42 and 70).
e found that the lethal potency of VX increased with the age of
emale, but not male, rats.
The 24 h LD50 values for pc exposure to VX were approximately
wice the values that we estimated for each age group and sex of
ats using the sc route of exposure and VX diluted in normal saline
PND 42 (males and females): 25.3 and 24.5 g/kg, respectively;
ND 70 (males and females): 19.0 and 21.1 g/kg, respectively;
31]) demonstrating the level of protection that is provided by the
kin. Misik et al. [17] found VX to be seven times more lethal in
ale rats (6–7 weeks old based on the reported body weight range)
hen administered sc rather than pc. However, they used a differ-
nt strain of rats and needed to dilute VX in 0.01% hexane to have
 large enough volume to pipette it onto the skin. The ability to
dminister VX in its neat form was essential for us as some sol-
ents reduce its dermal absorption depending upon their chemical
roperties [5].
Pubescent, female rats were less susceptible than both their
dult and male counterparts to the lethal effects associated with pc
xposure to VX. Estradiol becomes detectable in female rats on PND
8 and reaches adult levels by PND 48 [30]. The surge of this estro-
en hormone during puberty may  have, contrary to our hypothesis,
mproved the barrier function of the stratum corneum in female
ats. Harvell et al. [12] reported that TEWL values were lower on
he back and forearms of women just prior to ovulation when estro-
en levels are at their highest. In addition, estrogen replacement
herapy minimized the visible signs of aging in postmenopausal
omen by maintaining the thickness and moisture content of the
kin (reviewed in Ref. [24]).
The surge of estrogen during puberty may  have also had a pro-
ective effect irrespective of the skin as demonstrated by Smith
t al. [25], who showed that the 24 h LD50 value for sc expo-
ure to sarin was highest in female rats during the proestrus
tage of their hormonal cycle. Moreover, pretreating male rats
ith ethylestrenol caused a 150% increase in the LD50 value for
c exposure to parathion [23], an organophosphorus pesticide that
nhibits AChE similar to VX but with less potency. Pretreatment
ith diethylstilbestrol also increased the efﬁcacy of HI-6, an oxime
hat reactivates AChE, in castrated, male rats sc exposed to the
erve agents soman or tabun [16]. Given that estrogen therapy has
een shown to be beneﬁcial for a number of neurological disorders
reviewed in Ref. [26]), additional research is warranted to eluci-
ate the mechanism(s) by which estrogen might afford protection
gainst exposure to VX in the rat model.
As reviewed in Ref. [6], sex differences in the barrier function of
he stratum corneum are mainly limited to infants. Thus, it seems
nsurprising that there were no statistical differences between the
D50 values for male and female rats during early adulthood. Adult,
ale and female rats were also equally susceptible to the lethal
ffects associated with sc [31] or whole-body [2] exposure to VX.
[Reports 3 (2016) 895–899
In conclusion, age-related differences in susceptibility to the
lethal effects associated with pc exposure to VX were observed
with female, but not male, rats. The surge of estrogen hormones
during puberty may  afford female rats an innate protection against
nerve agent exposure; however, this needs to be followed up with
additional research. Nevertheless, this study underscores the need
to carefully control for both the age and sex of the animal when
evaluating the toxicological effects associated with nerve agent
exposure.
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